Exact Sciences Stock Plummets After Worse-Than-Expected Q3 Results, FY24 Guidance Below Estimates

Exact Sciences Corp. (NASDAQ:EXAS) shares are dropping after the company reported its third-quarter results after Tuesday's closing bell. Here's a look at the details.  

The Details: Exact Sciences reported quarterly GAAP losses of 21 cents per share, which missed the analyst consensus estimate for losses of 20 cents. Quarterly sales of $709 million missed the consensus estimate of $717.66 million.

“The Exact Sciences’ team is helping eradicate cancer while strengthening our platform ...